Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes
November 06, 2017 09:00 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust today announced five new grants that will support the European, multinational Global Platform for...
Patient Entrepreneur Finalists Announced for the 2017 Lyfebulb-Novo Nordisk Innovation Summit and Award
October 10, 2017 09:10 ET
|
Lyfebulb
NEW YORK, Oct. 10, 2017 (GLOBE NEWSWIRE) -- The finalists for the 2017 Lyfebulb-Novo Nordisk Innovation Summit and Award have been announced today. The Summit and Award spotlights outstanding...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
March 16, 2017 09:33 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
March 16, 2017 09:33 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...
FasterCures to Further Accelerate Biomedical Innovation with $3 Million Grant from Helmsley Charitable Trust
March 14, 2017 09:36 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, March 14, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust has awarded FasterCures, a center of the Milken Institute, a three-year, $3 million grant to support...
FRDJ et Lilly Canada financent à l'UCB des recherches susceptibles de permettre aux personnes ayant le diabète de type 1 de produire leur propre insuline
February 07, 2017 11:39 ET
|
JDRF/FRDJ
VANCOUVER, BC--(Marketwired - 7 février 2017) - FRDJ et Lilly Canada ont attribué une bourse de recherche postdoctorale de 60 000 $CA à une chercheuse prometteuse, la Dre Cara Ellis, boursière...
JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin
February 07, 2017 11:38 ET
|
JDRF/FRDJ
VANCOUVER, BC--(Marketwired - February 07, 2017) - JDRF and Lilly Canada have awarded a post-doctoral fellowship grant of CAN$60,000 to promising researcher Dr. Cara Ellis, a post-doctoral fellow...
Antidiabetics Market size worth USD 116 Billion by 2023: Global Market Insights Inc.
July 05, 2016 11:00 ET
|
Global Market Insights
Ocean View, Delaware, July 05, 2016 (GLOBE NEWSWIRE) -- Global Antidiabetics Market size is estimated to reach USD 116.1 billion by 2023; as per the latest research report by Global Market...
Helmsley Charitable Trust Awards $2.1 Million to Penn, Stanford and Seattle Children's Research Institute to Explore Cell-Based Therapies for Type 1 Diabetes
April 07, 2016 09:05 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, April 7, 2016 (GLOBE NEWSWIRE) -- The Type 1 Diabetes (T1D) Program of The Leona M. and Harry B. Helmsley Charitable Trust has announced $2.1 million in grants to support research toward the...
Helmsley Charitable Trust Awards $3.4 Million to DreaMed Diabetes for Type 1 Diabetes Decision Support
February 03, 2016 16:22 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, N.Y., Feb. 3, 2016 (GLOBE NEWSWIRE) -- The Type 1 Diabetes Program of The Leona M. and Harry B. Helmsley Charitable Trust today announced a $3.4 million grant for DreaMed Diabetes (DreaMed)....